Skip to content

How Will The Launch Of NPS Pharmaceuticals’ Orphan Drug Gattex (Teduglutide) For Short Bowel Syndrome Handle The Patient ?

October 7, 2012

         NPS Pharmaceuticals is making plans to launch orphan drug Gattex (Teduglutide) for the treatment of Short Bowel Syndrome (SBS) by providing “personalized patient services”.

         NPS Pharmaceuticals according to an October 1, 2012 Elsevierbi.com article (need a subscription), will use “Clinical Care Coordinators” to help launch Gattex to the patients.

         In the Career Section of NPS Pharmaceuticals’ website, there is a job posting for a “Care Coordinator” :

“ ….. responsible for facilitating the communication among the parties engaged in the care of the Gattex patient & will include planning and interacting with the patients, providers, physicians and their staff, pharmacies, home health, …… will be primary point of contact for patients …“.

          At the September 12, 2012 Morgan Stanley Global healthcare Conference, Mr. Nader discusses the steps for the commercialization of Gattex (Orphan Druganaut September 13, 2012 Blog Post) :

1. To find acute patients by reaching out to them one at a time

2. Use of social media to reach out to patients & advocacy groups

3. Engagement of the payers

4. Offering of internal help & “personalized service to patients” – “care coordinators” – to provide patients with support for how to navigate reimbursement process, how to use Gattex, how to reduce PN, etc.

5. A very narrow specialized targeted distribution with multiple players (GI physicians, home healthcare person, pharmacy, etc.).

       The FDA GI Drugs Advisory Committee Meeting is scheduled for October 16, 2012, where “the safety and efficacy of new drug application (NDA) 203441, with proposed trade name Gattex (Teduglutide) for subcutaneous injection, by NPS Pharmaceuticals, Inc, for the proposed indication of treatment of adult patients with Short Bowel Syndrome (SBS)” is to be discussed.

       The FDA PDUFA target date for Gattex is December 30, 2012.

References

NPS Pharmaceuticals June 2012 Presentation at Jefferies Global Healthcare Conference – Francois Nader, President & CEO

SeekingAlpha.com September 12, 2012 Presentation Transcription

Copyright © 2012-2013, Ann-Teresa Cusenza and Orphan Druganaut Blog. All rights reserved.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: